In the U.S. 30 million Americans suffer from a form of fatty liver disease that turns into a form of liver cirrhosis that leads to death unless a patient can receive a liver transplant. Now drug companies are spending billions to help find a cure.
There are several promising drug candidates to combat obesity, one of America's biggest diseases and contributors to mortality. Still, doctors have been slow to call obesity a disease, and insurance coverage remains skimpy.
CNBC's Meg Tirrell reports on a new form of gene therapy for hemophilia.
BioMarin's clinical trial of a gene therapy for hemophilia is providing hope to patients with the disease. It is an experimental treatment that uses a virus to deliver a healthy copy of a gene to make up for one that causes excessive bleeding.
CNBC's Meg Tirrell explains why major pharmaceutical companies are competing to come up with successful gene therapy treatments for hemophilia.
The effectiveness of the flu shot wanes over time so it's best not to get it too early in the season, according to several recent studies. It takes 10 to 14 days to get the vaccine levels in your system so you are protected.
Testosterone replacement therapy is gaining wider use, but there are potential health risks. These include heart attack and stroke in men over 65 and infertility in young men.
Allergies are on the rise and researchers are trying new methods to help combat potentially life threatening reactions.
CNBC's Meg Tirrell reports on what some drug companies are doing to fight increasing rates of food allergies in children.
CNBC's Meg Tirrell reports on the growing severity of food allergies in children and what some drug companies are doing to combat the issue.
The DEA approved the first-ever cannabis-derived drug on Thursday. For children with a rare form of epilepsy, like Paeyton Reuther, CBD provides relief no conventional drug has ever offered.
The FDA received high marks this week for calling teenage use of e-cigarettes like Juul an 'epidemic,' but in pointing the finger at makers of addictive nicotine vaping products, the FDA neglected a key culprit in the health crisis: itself.
Dr. James Kirkland, Mayo Clinic's Center on Aging director, joins 'Squawk Box' to discuss his new drug, research involving senolytic cells and how they combat age-related diseases.
Researchers at the University of Chicago have developed and tested a way to block cocaine craving and addiction, protecting addicts from high doses that would otherwise be deadly.
Sen. John McCain's death Saturday once again sheds light on this devastating illness and the need to find a cure.
A drug at the center of a $510 million deal five years ago by Gilead Sciences was sold by the Foster City-based drug developer for $3 million. The buyer, Sierra Oncology, has plans to use the drug, called momelotinib, to treat anemia.
Melanoma is more likely than most cancers to spread to the brain, and once it gets there, fewer than 20 percent of patients survive one year with traditional treatments. Yet a new study offers a glint of hope.
Lyme disease is spreading nationwide and infecting people of all ages. The crisis is spurring researchers to develop new tests to better diagnose the disease — and a vaccine.
Even more of a crisis than the chilling number of people suffering from anxiety — 40 million in the U.S. — is the number of people who are addicted to the drugs that treat it, along with the rising number of people dying from overdoses.
Medicare fraud is a huge problem that costs the government as much as $60 billion a year, and abuse of federal health care spending is rising in hospice care, according to a report from the Department of Health and Human Services.
In an era of rapid technological advances and demographic change, how do legacy companies adapt, innovate and evolve? CNBC Evolve features iconic global companies and executives who are embracing change and transforming for the future.
Coverage of the world's largest retail trade organization's annual conference.
Automation, AI and machine learning will radically influence the relationship between employers and their workforce.
Diana Olick joins 'Closing Bell' to report Peloton's quarterly results.
Michael "Mick" Farrell, CEO of ResMed, says that his company has been ramping up production of ventilator equipment to meet surging global demand as countries battle the coronavirus outbreak.
The World Health Organization (WHO) is currently working with different agencies and firms internationally to improve supply chain management and scale up manufacturing to meet this demand, says the WHO's chief scientist Soumya Swaminathan.
The aim is to keep a tamper-proof digital record of temperature-sensitive vaccines and pick up on any irregularities in their storage.
Nebraska Gov. Pete Ricketts joins "Squawk on the Street" to discuss the state's response to Covid-19 and the hospitalization numbers in the state.
Rite Aid has given more than 5,000 Covid vaccations so far and it's seen the rollout's challenges firsthand, its CEO said.
CNBC's Becky Quick breaks down UnitedHealth's fourth-quarter earnings results.
The Trump administration will be unable to get the discount cards out to beneficiaries.
While you can switch to a different Advantage Plan through March 31, there are some key aspects of coverage to check before you finalize your decision.
Pfizer's Covid-19 vaccine is authorized for people age 16 and older. The company's trial in kids 12-15 is now fully enrolled, a key step for use in kids.
President Joe Biden has painted a bleak picture of the nation's coronavirus outbreak, warning that it will take months to turn around the pandemic's trajectory
The CDC says the two products are not interchangeable, but it added in updated guidance posted Thursday that it's OK to mix the shots in rare circumstances.
Investors are taking note of the success enjoyed by Sutter Hill Ventures, a longstanding firm that has gone big on incubating start-ups and growing them fast.
Apps could take the place of paper cards to prove you've gotten the vaccine -- but will anybody accept them? And if so, which one?
You can search your whole iPhone, switch between apps, access widgets or quickly access shortcuts to things like your flashlight or Wi-Fi controls.